Siemens Healthineers

Siemens Healthineers will pay €300 million for the three-year transition period and will then operate independently under the name Healthineers. The renaming is intended to create transparency, avoid confusion with the parent company, and reflect its successful path as an independent business. The transition should be easy, since the company has already used the Healthineers name element since 2016. » Więcej na faz.net

Siemens will reduce its stake in Healthineers by 30 percentage points; the spin-off is to be approved by shareholders of both companies in 2027. Healthineers will change its name during a three-year transition period and pay €300 million for this; at the same time the board proposes a dividend of €1 per share. The diagnostics division will be spun off and renamed Olyrian Diagnostics, affecting about one in five employees; the general ultrasound business will be discontinued. The company is launching a cost program and expects revenue growth of 4–5% and earnings per share of €2.20–2.40 for the new fiscal year. » Więcej na faz.net

The medical-technology group intends to rename itself simply Healthineers within three years; the annual general meeting in February 2027 must still formally approve this. Siemens will reduce its stake to a minority and transfer around 30% of the shares to Siemens shareholders. The lab diagnostics division is to be gradually renamed Olyrian Diagnostics and spun off or sold. To offset the additional costs associated with the separation, Healthineers is launching the efficiency program "Transform4 Future" for 2028–2030; the outlook calls for comparable revenue growth of 4–5% and adjusted earnings per share of €2.20–2.40. » Więcej na manager-magazin.de

If €1,000 had been invested in Siemens Healthineers a year ago, investors would have €845.36 today, a loss of 15.46%. The stock closed on Oct. 21, 2026 at €41.71; a year earlier the price was €49.34. Market capitalization most recently €46.38 billion; calculation does not account for splits or dividends. » Więcej na finanzen.net

Siemens Healthineers is expected to publish figures for the quarter ended 30 September 2026 on 5 November 2026. Ten analysts on average expect earnings per share of €0.673 (previous year: €0.520), and nine analysts see revenue rising by about 7.19% to €6.78 billion (previous year: €6.32 billion). For the recently ended fiscal year, 21 analysts forecast average earnings per share of €2.35 and 20 analysts forecast revenue of €23.57 billion. » Więcej na finanzen.net